Table 2

Number of genes differentially expressed between HT users and non-users (in the Limma analysis)

HT type

Total sample N

Single users1 N

Number of genes FDR <0.25


HT all types

52

23

5(9)2

E2 or E2/P systemic

32

15

33

E2 systemic

9

7

10

Tibolone

10

2

400

Tibolone23

10

10

0(58)3

Thyroxine

20

5

8

Non-users

98

98


1 Users of other medication excluded.

2 FDR <0.28, 5 genes with FDR <0.25

3 All tibolone users were included in the analysis; there were 58 genes with FDR <0.50

Waaseth et al. BMC Medical Genomics 2011 4:29   doi:10.1186/1755-8794-4-29

Open Data